Open AccessDrug-eluting beads transarterial chemoembolization sequentially combined with radiofrequency ablation in the treatment of untreated and recurrent hepatocellular carcinoma
Author(s) -
Yan Zhang,
Meiwu Zhang,
Xiaoxiang Fan,
Dafeng Mao,
Quanhua Ding,
Lu-Hui Zhuang,
Shihui Lv
Publication year - 2020
Publication title -
world journal of gastrointestinal surgery
Language(s) - English
Resource type - Journals
ISSN - 1948-9366
DOI - 10.4240/wjgs.v12.i8.355
Subject(s) - medicine , hepatocellular carcinoma , radiofrequency ablation , gastroenterology , incidence (geometry) , magnetic resonance imaging , surgery , adverse effect , group b , progressive disease , liver cancer , ablation , chemotherapy , radiology , physics , optics
Drug-eluting beads transarterial chemoem-bolization (DEB-TACE) has the advantages of slow and steady release, high local concentration, and low incidence of adverse drug reactions compared to the traditional TACE. DEB-TACE combined with sequentially ultrasound-guided radiofrequency ablation (RFA) therapy has strong anti-cancer effects and little side effects, but there are fewer related long-term studies until now.